myPHteam

What information would you like to know about Uptravi medication for your PAH?

Uptravi (selexipag) is a prostacyclin receptor agonist that's FDA-approved for treating pulmonary arterial hypertension. It works by mimicking the effect of prostaglandins to help open up blood vessels in your lungs.

Here are some key points Show Full Answer

What information would you like to know about Uptravi medication for your PAH?

Uptravi (selexipag) is a prostacyclin receptor agonist that's FDA-approved for treating pulmonary arterial hypertension. It works by mimicking the effect of prostaglandins to help open up blood vessels in your lungs.

Here are some key points about Uptravi:

- It's taken orally as a tablet, which can be more convenient than some other PAH medications that require infusion or inhalation
- It may help slow disease progression and potentially reverse some heart and lung damage caused by PAH
- It has been shown to improve exercise ability
- Like all PAH medications, it can have side effects that you should discuss with your doctor

Many people with PAH take a combination of medications for better symptom control. If you're starting Uptravi or considering it, talk with your healthcare provider about what symptoms it will help address and what side effects to watch for.

Is there something specific about Uptravi you'd like to know more about?

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Pulmonary Arterial Hypertension (PAH) Diagnosis and Treatments

4 PAH Pathways Explained: How Treatments Target Them